|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||1.97|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a video highlighting the Company’s product pathway and platform. In the video CEO Phil Bosua discusses the Company’s Bio-RFID™ technological breakthrough and the plans for bringing the technology to market.
Know Labs, Inc. (KNWN) – the developer of the calorie counter UBAND™ wearable and its underlying non-invasive continuous glucose monitoring technology, announced today that James Anderson, MD, has joined the Company as Medical Director. Dr. Anderson will also serve as Chairman of the Company’s Medical, Scientific and Regulatory Affairs Advisory Board. Phil Bosua, Know Labs CEO, stated, “Dr. Anderson immediately understood the science underlying our technology, and shares our vision for its application to medical diagnostics and therapeutics.
Know Labs, Inc. (KNWN) – a provider of identification, authentication and diagnostic solutions, published an advertisement in the Seattle Times newspaper today announcing its UBAND™ real time wearable calorie counter wrist band. The Calorie Counter UBAND is built upon the Company’s recent invention that detects blood glucose non-invasively. Know Labs, Inc. (f/k/a Visualant Incorporated) is a public company whose shares currently trade under the stock symbol “KNWN.” The company’s technology directs structured light or radio waves through a substance or material to capture a unique molecular signature.
Know Labs, Inc. (KNWN) – a provider of identification, authentication and diagnostic solutions, released today a video overview of comparison tests of the Company’s invention of a new way to detect blood glucose non-invasively and the DexCom G5®. In the video, Company CEO Phil Bosua discusses the breakthrough and highlights a comparison of the Know Labs Bio-RFID™ technology with an industry leading continuous glucose monitor from DexCom, Inc. (DXCM). “We’ve just invented a holy grail of the bio-tech industry – non-invasive – blood glucose monitoring.
Know Labs, Inc. (f/k/a Visualant, Incorporated) (KNWN) – a provider of identification, authentication and diagnostic solutions, released today a video of the Company’s invention of a new technology to detect blood glucose non-invasively. In the video, Company CEO Phil Bosua briefly discusses the breakthrough. “We’re developing a brand-new technology platform that measures blood glucose - non-invasively.
Know Labs, Inc. (f/k/a Visualant, Incorporated) (KNWN) – a provider of identification, authentication and diagnostic solutions, announced today that Michael Grabham has been appointed Chief Business Officer of the Company. Michael Grabham is a Seattle serial entrepreneur who has started six companies over the past 25 years. Grabham has led, as President, several companies from a regional telecommunications company ($14M annual sales) to a software assessment company (startup).